Research programme: VLA-4 antagonists - Uriach
Alternative Names: Integrin-alpha4beta1 antagonists; UR-13484; VLA-4 antagonists research programme - UriachLatest Information Update: 17 Aug 2007
At a glance
- Originator Uriach
- Class Small molecules
- Mechanism of Action Integrin alpha4beta1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Inflammatory bowel diseases; Multiple sclerosis
Most Recent Events
- 17 Aug 2007 No development reported - Preclinical for Asthma in Spain (unspecified route)
- 17 Aug 2007 No development reported - Preclinical for Inflammatory bowel disease in Spain (unspecified route)
- 17 Aug 2007 No development reported - Preclinical for Multiple sclerosis in Spain (unspecified route)